Lemaitre Vascular (LMAT) Receivables - Net (2010 - 2026)
Lemaitre Vascular's (LMAT) quarterly Receivables - Net came in at $35.7 million in Q2 2026, down 2.34% year-over-year from $36.5 million in Q2 2025, and little changed quarter-over-quarter from $35.8 million in Q1 2026.
Analysis
Lemaitre Vascular (LMAT) Receivables - Net (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Receivables - Net for 17 consecutive years, with $35.7 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Receivables - Net fell 2.34% year-over-year to $35.7 million in Q2 2026; TTM through Jun 2026 was $35.7 million, a 2.34% decrease from a year earlier, with the FY2025 full-year figure at $33.6 million, up 11.8% from the prior year.
- Receivables - Net was $35.7 million for Q2 2026 at Lemaitre Vascular, roughly flat from $35.8 million in the prior quarter.
- Over five years, Receivables - Net peaked at $36.5 million in Q2 2025 and troughed at $20.1 million in Q3 2022.
- A 5-year average of $28.8 million and a median of $30.1 million in 2024 frame the typical range for Receivables - Net.
- Across the five-year window, Receivables - Net surged 35.12% in 2024 and declined 2.34% in 2026, its largest moves.
- Over 5 years, Receivables - Net stood at $22.0 million in 2022, then gained by 13.72% to $25.1 million in 2023, then increased by 19.94% to $30.1 million in 2024, then rose by 11.8% to $33.6 million in 2025, then gained by 6.16% to $35.7 million in 2026.
- The last three Receivables - Net figures came in at $35.7 million (Q2 2026), $35.8 million (Q1 2026), and $33.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Lemaitre Vascular | 1.80 Bn | 1.43 Bn | 50.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 35.68 Mn |
| Mar 31, 2026 | 35.77 Mn |
| Dec 31, 2025 | 33.61 Mn |
| Sep 30, 2025 | 32.42 Mn |
| Jun 30, 2025 | 36.54 Mn |
| Mar 31, 2025 | 35.11 Mn |
| Dec 31, 2024 | 30.06 Mn |
| Sep 30, 2024 | 32.27 Mn |
| Jun 30, 2024 | 30.82 Mn |
| Mar 31, 2024 | 30.24 Mn |
| Dec 31, 2023 | 25.06 Mn |
| Sep 30, 2023 | 23.88 Mn |
| Jun 30, 2023 | 26.41 Mn |
| Mar 31, 2023 | 25.37 Mn |
| Dec 31, 2022 | 22.04 Mn |
| Sep 30, 2022 | 20.09 Mn |
| Jun 30, 2022 | 21.54 Mn |
| Mar 31, 2022 | 21.39 Mn |
| Dec 31, 2021 | 19.63 Mn |
| Sep 30, 2021 | 19.50 Mn |